EMJ GOLD - European Medical Journal

Continue

Pharma News, Views & Analysis

Filter Advertise With Us
Researchers

Gene therapy from Novartis shows promise for children with SMA

Novartis’ Phase III study has demonstrated significant improvement in motor function in children and young adults with spinal muscular atrophy

Spoonful of technology: Nov-Dec 2024

Discover the latest examples of how pharma and its partners are working together to develop technology to solve key industry challenges.
The word spotlight on a blue background

Spotlight: December 2024

Catch up on all the latest pharmaceutical industry news from the past month, from breakthroughs in gene therapy to promising drug approvals and more.
stamp of approval

Eli Lilly’s tirzepatide wins FDA nod for sleep apnea

Eli Lilly’s weight-loss drug tirzepatide has become the first drug for obstructive sleep apnea, a common but serious sleep disorder.

Tessera's sickle cell gene therapy wins Gates Foundation backing

Tessera Therapeutics has announced a partnership with the Bill & Melinda Gates Foundation, securing funding of up to $50m.
Orange lungs on yellow background

Respiratory infections cost UK businesses £44bn annually

A new report by the Office of Health Economics (OHE), commissioned by Pfizer, reveals that respiratory infections can be bad for business.
Handshake on a green background

Lilly gains EU backing for drug to treat Crohn’s disease

The drug has received a nod from the European Medicines Agency’s Committee for Medicinal Products for Human Use (CHMP).
contract

Dr Dietmar Berger appointed as Gilead’s next Chief Medical Officer

Dr Dietmar Berger is set to join Gilead Sciences as Chief Medical Officer on 2 January 2025 – succeeding Dr Merdad Parsey.